1. Home
  2. MTH vs GRFS Comparison

MTH vs GRFS Comparison

Compare MTH & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Meritage Homes Corporation

MTH

Meritage Homes Corporation

HOLD

Current Price

$65.54

Market Cap

4.1B

ML Signal

HOLD

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$8.72

Market Cap

5.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MTH
GRFS
Founded
1985
1940
Country
United States
Spain
Employees
N/A
25247
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
5.5B
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
MTH
GRFS
Price
$65.54
$8.72
Analyst Decision
Buy
Hold
Analyst Count
8
2
Target Price
$83.38
$10.15
AVG Volume (30 Days)
869.1K
683.5K
Earning Date
04-22-2026
07-28-2022
Dividend Yield
2.88%
1.68%
EPS Growth
N/A
N/A
EPS
6.35
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$4.69
Revenue Next Year
$9.78
$6.49
P/E Ratio
$10.50
$18.67
Revenue Growth
N/A
N/A
52 Week Low
$58.03
$6.86
52 Week High
$84.54
$11.14

Technical Indicators

Market Signals
Indicator
MTH
GRFS
Relative Strength Index (RSI) 51.71 60.96
Support Level $64.80 $8.66
Resistance Level $75.71 $8.94
Average True Range (ATR) 1.84 0.20
MACD 0.96 0.12
Stochastic Oscillator 76.60 97.67

Price Performance

Historical Comparison
MTH
GRFS

About MTH Meritage Homes Corporation

Meritage Homes Corp is engaged as a designer and builder of single-family attached and detached homes. It has operations in three regions: West, Central, and East, comprising twelve states: Arizona, California, Colorado, Utah, Tennessee, Texas, Alabama, Florida, Georgia, Mississippi, North Carolina, and South Carolina. The company operates with two principal business segments: homebuilding and financial services. The homebuilding segments are engaged in the business of acquiring and developing land, constructing homes, marketing and selling those homes, and providing warranty and customer services, and the financial services segment offers title and escrow, mortgage, and insurance services. The company generates key revenue from the Homebuilding segment.

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Share on Social Networks: